Senegal vs United States: Proportion of the target population who received the final dose
Senegal
51.0%
in 2024
United States
52.0%
in 2024
Senegal rank
73rd
United States rank
71st
Proportion of the target population who received the final dose over time
- Senegal
- United States
How they compare
United States currently reports 52.0% against 51.0% in Senegal, a difference of 1.0%.
Across all 6 years both countries report, United States has been ahead every year.
Senegal ranks 73rd and United States ranks 71st of 108 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Senegal | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.0% | 49.0% | 23.0% | United States |
| 2020s | 36.6% | 50.8% | 14.2% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Senegal or United States?
- United States, at 52.0% against 51.0% in Senegal as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Senegal and United States?
- 1.0%, with United States ahead.
- How many years of comparable data are there for Senegal and United States?
- 6 years are reported by both, from 2019 to 2024.
- How do Senegal and United States rank globally for proportion of the target population who received the final dose of?
- Senegal ranks 73rd and United States ranks 71st of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.